A citation-based method for searching scientific literature

Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
Times Cited: 390



Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
Times Cited: 393




List of shared articles



Times cited

Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway.
Xingxing Hu, Menglin Zou, Lan Ni, Mingyang Zhang, Weishuai Zheng, Bing Liu, Zhenshun Cheng. Front Pharmacol 2022
0

ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation.
Dongxin Chen, Huirong Tang, Hongchao Jiang, Lei Sun, Wenjuan Zhao, Feng Qian. Front Pharmacol 2022
0

Antithrombin III as predictive indicator of survival in idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib: a preliminary study.
Laura Bergantini, Miriana d'Alessandro, Paolo Cameli, Alfonso Carleo, Claudia Landi, Lucia Vietri, Nicola Lanzarone, Maria Pieroni, Piersante Sestini, Elena Bargagli. Intern Med J 2021
6

Cytokine Adsorption to Polymyxin B-Immobilized Fiber: An in vitro Study.
Toshiaki Utsunomiya, Yuka Mimura-Kimura, Takeshi Yamamoto, Keisuke Aoe, Keiji Oishi, Haruhito Kamei, Kazuto Matsunaga, Masafumi Yano, Yusuke Mimura. Blood Purif 2021
3

Pharmacological management of Idiopathic Pulmonary Fibrosis: current and emerging options.
Athina Trachalaki, Mujammil Irfan, Athol U Wells. Expert Opin Pharmacother 2021
8